12 Health Care Stocks Moving In Friday's Intraday Sessionbenzinga_article·Jul 24 at 12:05 PMVTAK+10.35%HOWL+3.77%
Werewolf Therapeutics director Luke Evnin reports disposal of common shares worth $44,155.83PUBT·Jul 8 at 04:34 PMHOWL+3.77%
Werewolf Therapeutics director Luke Evnin disposes of 157,084 common shares for $47,125.2PUBT·Jun 29 at 06:08 PMHOWL+3.77%
RA Capital Management disposes of Werewolf Therapeutics shares worth $145,069PUBT·Jun 22 at 06:00 PMHOWL+3.77%
Luke Evnin Sells 22,184 Shares of Werewolf Therapeutics (NASDAQ:HOWL) StockMarket Beat·May 21 at 07:24 AMHOWL+3.77%IBB+0.11%
Werewolf Reports Q1 Loss Of $13 Mln, Highlights Asset Purchase Agreement With Jazznasdaq·May 8 at 05:55 AMHOWL+3.77%JAZZ+0.62%
Werewolf Therapeutics | 8-K: FY2026 Q1 EPS Beats Estimate at USD -0.28Earnings Watch·May 7 at 03:26 PMHOWL+3.77%
Pre-market hot trades in US stocks: Wingstop pre-market down 8.65%; Werewolf Therapeutics pre-market up 7.97%Price Alert·Apr 29 at 06:57 AMWING+1.61%HOWL+3.77%
Werewolf Therapeutics Faces Nasdaq Delisting Risk After Falling Below $1 Minimum Bid PriceTip Ranks·Mar 28 at 01:05 AMSBIO+1.16%LABU+4.00%
